![Robert Brodsky Profile](https://pbs.twimg.com/profile_images/1586417963728605184/x5Q8_NSj.jpg)
Robert Brodsky
@DocsDock200
Followers
3K
Following
72
Media
84
Statuses
281
ASH President 2023 @ASH_Hematology. Chief of Hematology Johns Hopkins.
Maryland, USA
Joined October 2022
Just walked thru NOLA convention center. All set for #ASH2022. Place looks great. 80 degrees and sunny.
1
14
198
Important advance for patients with severe aplastic anemia in latest issue of Blood: Upfront haploidentical BMT. @pnhaacontact @aamdsif #aplastic
4
68
187
Fantastic #ash22! Great science and medicine. Power of in person meeting with over 25k palpable. Thx @JaneWinterMD and kudos to ash staff. I look forward to serving as President of this amazing society that does so much for pts with blood diseases.
8
16
154
#hematology predictions for 2023: 1) single-board #classicalhematology will become fastest growing subspecialty in internal medicine. Thanks #HFFTP; 2) #bmt: Indications for BMT will decline for malignant disease. .
4
19
129
Shifting paradigm in treating severe aplastic anemia (SAA). #AA&MDSIF #aplasticanemia #bonemarrowfailure
2
35
116
For those of you who remember ASH history, I think I just outdid @jmikhaelmd and @MikkaelSekeres. They had a lot of ribbons but I think I have the most family badges😂. So grateful to have everyone here with me. Pres. elect Narla may be a challenge.
4
3
109
ASH has 3 mascots! Red is already saturated with knowledge. Leuk was on Boubon street playing it cool. He met a girl (Poly) and formed a band. They were having a blast! The noise gave Meg a headache. She took asa n now won't adhere to ASH rules. Dedicated to @redcell_doc
1
8
72
Of all the events at ASH, Ashapalooza is among my favorite. Trainees are the future of hematology. Love their passion and enthusiasm. So bright and dedicated. Enjoy the ride. Amazing field (Pun) to be in! #Ash23 @ASH_hematology
1
6
72
Dr. Rakhi Naik @redcell_doc has been named the new Director of the Organ Systems Foundations of Medicine (OSFM) course for Year 1-2 medical students at the Johns Hopkins University School of Medicine. JHU Med students very fortunate.
2
2
57
ASH meeting #ASH2023 is just 3 months away. Don't miss Ernest Beutler lecture and Prize. Will feature development and use of emicizumab - one of the most creative hematology drugs in the past 20 years!
3
8
54
Important paper with big implications for gene editing/therapy for hemoglobinopathies. @BloodJournal
1
14
57
Evolutionary beginnings of hematopoiesis, clotting, and complement. #classicalheme #chesapeakebay. Science is so cool.
1
0
48
ASH23 Practice Changing LBAs are out! 1)Perseus trial primary results. (dex,VRd over VRd) #myeloma 2)BMT-CTN1507: HaploBMT in adults with severe SCD. Curative therapy for SCD. Widely available in US. Cure rates ~90%. 10x less expensive than gene therapy/editing. #sicklecell.
1
15
46
#ASH23 educational program is exceptional. So impressed by all the hard work of our 2023 educational co-chairs @AmyDeZern and @connors_md.
1
6
44
10) #ASH23 with attract over 30k in-person registrants. Happy and healthy New Year to all! See you in San Diego.
0
6
41
Don't miss #ASH23! I just spent 2 full days in San Diego with several of the ASH brain trust. Such an amazing group of dedicated people who make ASH what it is. Look what was on the the menu. It's going to be a spectacular meeting.
1
2
36
2023 Ham-Wasserman lecture #ASH23 by Andreas Greinacher on thrombotic anti-PF4 Immune Disorders. Learn about classification of anti-PF4 Abs: 1) non-pathogenic, non plt activating 2) heparin dependent & plt activating 3) heparin independent & plt activating.
1
7
39
Hematology workforce shortage? How we got here and how we are addessing it. #ASHTrainee#classicalheme#HFFTP
1
14
38
Program directors and Med students/residents interested in hematology. This is the wave 🌊 of the future. Don't miss this amazing opportunity from @ASH_hematology
0
15
29
Excited for #ASH23 presidential symposium on complement Dec. 12,2023 @11am. @roumenina wll discuss the canonical complement cascade with an emphasis on defense against pathogens and host cell damage. Next @CKemperLab will discuss . .
1
7
28
You all were magnificent!.
@ASH_hematology .Ready for the Presidential Symposium at #ASH23! Join the Presidential Symposium today from 11-12:30 PT chaired by @DocsDock200 to hear @elenicelli, @roumenina, & @CKemperLab ! #AshGreenRoom
0
0
28
Spent last week at ASH Headquarters for the annual meeting #ASH23 Program Committee joint meeting. Amazing job by co-chairs Drs. Elizabeta Nemeth and Kojo Elenitoba-Johnson! We'll probably set a record for PhD speakers/Chairs in Scientific program. Great science!.
0
4
25
Don't miss this. I'll be giving out a special surprise.
ASH-a-Palooza is all about micro-learning, mentorship, networking, and more! Come hang out and network with your peers on Friday, December 8 at 12:45-5:00p.m. at Petco Park. The event will also be streamed on the #ASH23 virtual platform. Learn more:
0
5
22
Check out the ASH Foundation and the ASH Donor Lounge in SD. A $250 donation gains you access to the lounge (beat the long coffee lines). 100% of funds go to ASH programs. @ASH_hematology
2
4
21
So proud of @elenicelli and @BloodClotDoc . I can't say rising stars anymore. They're just stars.
0
0
22
. especially ALL, B cell lymphoma, CLL, and myeloma as non-transplant therapies improve (drugs, bispecifics, CAR-T, checkpoint inhibitors); 3) #bmt BMT indications for classical heme will increase as safety of allogeneic BMT increases. .
1
2
21
. haplo BMT with PTCy has higher cure rate than ATG/CSA/Epag and haplo BMT for SCD will have cure rates approaching 90%; 4) #MPD early treatment with interferon-based therapy will become standard for PV - decrease clonal burden;.
2
1
20
7) #complement oral complement inhibitors will become available for PNH; 8)#myeloma bispecifics will outdual CAR-Ts for MM; 9)#AML use of dose intensive induction will decline, even in more fit patients;.
1
1
20
We mostly focus on the acute disease and manage with plasma exchange, rituximab and caplacizumab but new research from @BloodClotDoc teaches us that TTP pts continue to have silent and symptomatic cerebral infants even in remisssion. @ASH_hematology @HopkinsHeme
1
3
17
Don't miss the 2023 EHA-ASH Joint symposium - Lymphoma: The way forward. 6/10/23, 9:45am Fantasie. I will co-chair with EHA President Elizabeth Macintyre. @eha2023 #Frankfurt @ASH_hematology
0
0
19
Listening to ASH CRTI trainees deliver their 3 min elevator talk in La Jolla, CA. Such an impressive group! #ASHproud
0
2
17
5) #CLL BTK degraders will encroach on BTK inhibitors - decrease resistance mutations; 6) #hemostasisthrombosis contact pathway inhibitors will begin to encroach on warfarin and factor X inhibitors for DVT prevention;.
1
2
18
Huge shout out to @jkw444, @Ashley_Rosko1 and @KerryARogersMD aka travel buddies! They all gave spectacular talks at ASH highlights in Hanoi. Without them I might not not have made my way back😂. Big perk of being ASH Pres is getting to know wonderful people. Thx!!!.
3
1
18
Welcome to JHU Heme.
We are so excited to welcome these brilliant Heme Track fellows to our @HopkinsHeme #HemeDreamTeam!!. The future of hematology is so bright!! 🩸🌟🩸 #Match2024 #ASHHFFTP
0
0
17
@ASH_hematology has 4 wonder journals @BloodJournal @BloodAdvances @ASHClinicalNews The Hematologist - and 4 wonderful Editors - Nancy Berliner @CathBollard1 @AaronGerds @myelomaMD Stay tuned - new journals from ASH coming!
0
5
17
Alt path complement(APC) deep dive: C3,FD,FB,FP are 4 main proteins of APC. There r two C3 convertases in APC! Read this and previous tweetorial on HiCY and you'll be prepped for 2/6 LBAs at #ASH22.
1
4
16